Kamakshi V. Rao

ORCID: 0000-0002-5621-2366
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hematopoietic Stem Cell Transplantation
  • Pharmaceutical Practices and Patient Outcomes
  • Innovations in Medical Education
  • Acute Lymphoblastic Leukemia research
  • Multiple Myeloma Research and Treatments
  • Renal Transplantation Outcomes and Treatments
  • Polyomavirus and related diseases
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Health Sciences Research and Education
  • Medication Adherence and Compliance
  • Neutropenia and Cancer Infections
  • Pharmacological Effects and Toxicity Studies
  • Parvovirus B19 Infection Studies
  • Medical Education and Admissions
  • Cancer Treatment and Pharmacology
  • Diabetes Treatment and Management
  • Global Health Workforce Issues
  • HIV/AIDS drug development and treatment
  • Healthcare professionals’ stress and burnout
  • Eosinophilic Disorders and Syndromes
  • Health and Medical Research Impacts
  • Diabetes Management and Research
  • Problem and Project Based Learning

University of North Carolina Hospitals
2007-2024

University of North Carolina at Chapel Hill
2011-2023

University of North Carolina Health Care
2011-2019

UNC Lineberger Comprehensive Cancer Center
2015-2016

Indiana University School of Medicine
2012-2016

University School
2012

Indiana University
2012

American Society of Clinical Oncology
2011

Lahey Hospital and Medical Center
2011

Memorial Sloan Kettering Cancer Center
2011

<h3>Objective.</h3> —To determine whether optimized glycemic control in type I diabetic recipients of renal allografts will prevent or delay lesions the allograft. <h3>Design.</h3> —Prospective, controlled, and randomized trial an inception cohort allograft recipients. The experimental group underwent maximized control, standard was treated same way as other patients transplant clinic. Patients baseline (before transplant) 5-year posttransplant biopsies. <h3>Setting.</h3> —University...

10.1001/jama.1994.03520080042041 article EN JAMA 1994-08-24

Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon possible after acceptance. Accepted have been peer-reviewed and copyedited, but are posted before technical formatting author proofing. These not final version record will be replaced with article (formatted per style proofed by authors) at a later time.

10.1093/ajhp/zxaf029 article EN American Journal of Health-System Pharmacy 2025-02-08

The novel coronavirus identified in 2019 (COVID-19) pandemic has impacted pharmacy graduate and postgraduate education. This crisis resulted a cosmic shift the administration of these programs to ensure core values are sustained. Adjustments may be needed at minimum that trainees complete program requirements while maintaining safety. Moving forward, additional issues arise will need addressed such as admissions onboarding, acclimating students new training environments, managing inadequate...

10.5688/ajpe8158 article EN American Journal of Pharmaceutical Education 2020-06-01

PURPOSE To test the hypothesis that progression of androgen sensitive prostate cancer is dependent on growth factors, such as platelet derived factor (PDGF), and inhibition PDGF receptor (PDGF-R) with imatinib will induce anti-tumor activity. PATIENTS AND METHODS This phase II study evaluated in patients specific antigen (PSA) after local therapy. Patients received 400 mg orally twice a day for 24 weeks (six cycles). were monitored every 4 an effect PSA toxicity. Immunohistochemistry (IHC)...

10.1002/pros.20130 article EN The Prostate 2004-01-01

The optimal mobilization strategy prior to autologous stem cell transplantation for patients with multiple myeloma remains unclear. Mobilization cytokines alone appears yield suboptimal results in older as well who have received lenalidomide. To avoid the marked cytopenias and risks of hemorrhagic cystitis associated administration cyclophosphamide, we investigated efficacy safety chemomobilization an intermediate dose etoposide (VP-16; 375 mg/m(2) on days +1 +2) granulocyte-colony...

10.1016/j.bbmt.2010.06.021 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2010-07-16

The outcomes of a patient-centered layered learning practice model (LLPM) in which the clinical specialist acted as attending pharmacist and managed pharmacy team to provide direct patient care were evaluated.Two 30-day evaluations conducted on acute malignant hematology medical oncology services University North Carolina Medical Center 2011. primary objective this study was design an LLPM that used expand offered. outcome frequency encounters at discharge (medication reconciliation...

10.2146/ajhp150593 article EN American Journal of Health-System Pharmacy 2016-11-07

Purpose: The American Society of Health-System Pharmacists (ASHP) requires that accredited residency programs provide pharmacy residents the opportunity to perform a practice-based project. objective this study was evaluate impact research training on residents’ actual versus perceived ability solve practice-related problems in their professional careers. Methods: This cross-sectional surveyed postgraduate year 1 (PGY1) practice who completed at large academic medical center between 2007 and...

10.1177/0897190014566317 article EN Journal of Pharmacy Practice 2015-01-31

Tacrolimus exhibits high inter-patient pharmacokinetics (PK) variability, as well a narrow therapeutic index, and therefore requires drug monitoring. Germline mutations in cytochrome P450 isoforms 4 5 genes (CYP3A4/5) the ATP-binding cassette B1 gene (ABCB1) may contribute to interindividual tacrolimus PK which impact clinical outcomes among allogeneic hematopoietic stem cell transplantation (HSCT) patients. In this study, 252 adult patients who received for acute graft versus host disease...

10.3390/ijms21030858 article EN International Journal of Molecular Sciences 2020-01-29

The movement to deliver cancer care in resource-limited settings is gaining momentum, with particular emphasis on the creation of cost-effective, rational algorithms utilizing affordable chemotherapeutics treat curable disease. delivery resource-replete a concerted effort by team multidisciplinary providers. oncology pharmacy, which now considered integral resourced medical practice, developed over last several decades an limit healthcare provider exposure workplace hazards and risk...

10.1177/1078155211434852 article EN Journal of Oncology Pharmacy Practice 2012-01-16

Abstract Purpose The attainment of fundamental research skills to create and disseminate new knowledge is imperative for the advancement pharmacy practice. Research training an important component postgraduate residency training; however, traditional model performing has several limitations that have hindered ability residents complete high-quality projects. Therefore, our institution developed implemented flipped with 2013–2014 practice class. Summary modifies timeline better align...

10.1093/ajhp/zxz064 article EN American Journal of Health-System Pharmacy 2019-04-17

This study seeks to evaluate the impact of pharmacists' involvement in care patients undergoing bone marrow transplantation (BMT).This was a three-phase study. In phase 1, inpatient and outpatient pharmacist encounters were totaled services provided translated revenue generated from prescription billing charges. 2, activities interventions associated with time savings estimated by providers. 3, providers surveyed assess their expectations, experiences, value perceptions pharmacists.A...

10.1200/jop.2015.008797 article EN Journal of Oncology Practice 2016-02-01

Rao, K. V.; Sutherland, D.; Kjellstrand, C. M.; Najarian, J. S.; Shapiro, F. L. Author Information

10.1097/00002480-197700230-00112 article EN ASAIO Journal 1977-01-01

Abstract Introduction Hospital departments of pharmacy are experiencing significant challenges in the recruitment and retention trained hematology‐oncology pharmacists. The reasons for these varied, but one consistent challenge is growing attrition clinically‐trained pharmacists from patient care environment. Methods An electronic 21‐item survey was distributed to oncology across United States. assessed work environment, board certification, clinical commitment, other factors. How those...

10.1002/jac5.1693 article EN JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2022-08-11

Autologous stem cell transplantation remains a mainstay of therapy for diseases such as multiple myeloma and relapsed lymphoma. The use plerixafor has been shown to augment the ability collect adequate cells, but optimal this agent when used with chemotherapy is not yet clear. We utilized an algorithm-based approach addition 54 patients undergoing chemomobilization reduced-dose etoposide who had less than preapheresis CD34+ count. precount 20 cells/μL threshold initiate apheresis....

10.1016/j.bbmt.2014.03.023 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2014-04-03

Abstract Introduction Hematology/oncology pharmacists work in various roles healthcare systems and represent a highly skilled valuable resource. There remains significant challenge the recruitment retention of these well‐trained pharmacists. We sought to identify key factors propose solutions impact ability recruit, promote, retain Methods An initial survey 2021 assessed status oncology pharmacist workforce with regard job satisfaction attrition risk. Based on top 5 identified Initial...

10.1002/jac5.1954 article EN JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2024-05-03
Coming Soon ...